Last reviewed · How we verify

NCT03331185

Changes of Soft and Hard Tissues After Alveolar Ridge Preservation: Freeze-dried Bone Allograft vs. L-PRF Clot

Completed Phase 2, PHASE3 Results posted Last updated 30 April 2020
What this trial tests

Phase 2, PHASE3 trial testing Freeze Dried Bone Allograft in Alveolar Bone Loss in 26 participants. Completed in 2 April 2019.

Timeline
3 January 2018
Primary endpoint
2 April 2019
2 April 2019

Quick facts

Lead sponsorUniversity of Manitoba
PhasePhase 2, PHASE3
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment26
Start date3 January 2018
Primary completion2 April 2019
Estimated completion2 April 2019
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

University of Manitoba

Who can join

22 and older, any sex, with Alveolar Bone Loss or Tooth Loss. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Overall Horizontal Change in Alveolar Ridge Width Primary · Difference reported on horizontal changes comparing CBCT analysis 11weeks after extraction and grafting compared to CBCT following extraction and grafting

Calculated mean of post operative CBCT measurements of horizontal alveolar bone width changes following extraction and alveolar ridge preservation.

GroupValue95% CI
Freeze Dried Bone Allograft-1.34± 0.38
L-PRF Clot-2.21± 0.41
Buccolingual Change in Width of Keratinized Soft Tissue Secondary · Soft tissue measurement at time of extraction and grafting and 12 weeks after extraction and grafting

Difference in post operative measurement analysis of keratinized gingiva changes following extraction and alveolar ridge preservation

GroupValue95% CI
Freeze Dried Bone Allograft-1± 3.03
L-PRF Clot-4± 2.7
Post-operative Pain and Swelling Secondary · Measured at 7 days following extraction and grafting

Post-operative pain and complications measured by VAS-questionnaire obtained following extraction and grafting. The VAS-questionnaire contained the following categories to be answered 7days post-operatively: Pain, Swelling. A visual line scale of 100mm in length was provided with no pain/swelling on the one end and severe pain/swelling on the opposite end. Participants were instructed to rate their pain and swelling by marking a single line on the scale indicating the degree of pain/swelling they experienced. Markings were physically measured on the scale and converted into a score with 0 repr

GroupValue95% CI
Freeze Dried Bone Allograft0.22± 0.29
L-PRF Clot0.23± 0.30

Adverse events — posted to ClinicalTrials.gov

Time frame: 12weeks. Reporting threshold: 0%. Adverse-event reports describe events observed during the trial — not all are caused by the drug.

Freeze Dried Bone Allograft
Serious: 0/14 (0%)
Deaths: 0/14
L-PRF Clot
Serious: 0/12 (0%)
Deaths: 0/12
Other adverse events (1 terms — click to expand)

ReactionSystemFreeze Dried Bone AllograftL-PRF Clot
Membrane loss earlier than 4weeksSurgical and medical procedures

Data from ClinicalTrials.gov NCT03331185 adverse events section.

Sponsor's own description

A Clinical Trial to study the effectiveness between two, tooth socket grafting materials namely, Freeze Dried Bone Allograft (human derived bone particles) and Leukocytic-Platelet Rich Fibrin (the patient's own centrifuged blood). The purpose of this study is to compare the effects (good and bad) of Bone Allograft to Platelet Rich Fibrin to see which material would be the most effective in maintaining the volume of the gum and bone of the jaw during the healing phase as well as minimizing the amount of pain and/or swelling following tooth extraction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Alveolar Bone Loss

Currently open trials in the same condition.

Other University of Manitoba trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03331185.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing